Fattori prognostici di farmacoresistenza nell'epilessia dell'infanzia e dell'adolescenza

Translated title of the contribution: Prognostic factors of drug resistance in childhood and adolescence epilepsy

A. Russo, A. Posar, S. Conti, A. Parmeggiani

Research output: Contribution to journalArticle

Abstract

The International League Against Epilepsy (ILAE) has recently defined drug resistance (DR) as a failure of adequate trials of two tolerated and appropriately chosen and used AED schedules (whether as monotherapies or in combination) to achieve sustained seizure freedom. We studied the prognostic factors of DR in 117 patients affected by epilepsy with onset during childhood or adolescence, with a mean age at the first and the last observation respectively of 3 yrs 3 mths and 9 yrs 10 mths. Patients were divided into two groups: one with DR and the other one without DR. In DR cases some parameters prevailed, in particular presence of symptomatic etiology, lesions on MRI, EEG abnormalities at the onset and positive neurological examination, seizure frequency and seizure clustering, poor or delayed response to first AED. PB, VPA, and CBZ were the most utilized drugs. We reviewed the most relevant 10 variables by multiple logistic regression. The most reliable combinations of DR predictors are: partial or no response to the first AED, the presence of seizure clustering during the course of epilepsy, slightly or very altered neurological examination and long latency between onset of epilepsy and first AED administered at T2; partial or no response to the first AED and positive MRI at T5; positive MRI and absence of generalized seizures at T8; and positive MRI at T10. Our data show that 14.4% of the subjects at T5, 16.6% at T8 and 24.3% at T10 became drug-resistant after discontinuation of an efficacious therapy.

Original languageItalian
Pages (from-to)117-124
Number of pages8
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number145
Publication statusPublished - Apr 2013

Fingerprint

Drug Resistance
Epilepsy
Seizures
Neurologic Examination
Cluster Analysis
Absence Epilepsy
Pharmaceutical Preparations
Electroencephalography
Appointments and Schedules
Logistic Models
Observation

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Fattori prognostici di farmacoresistenza nell'epilessia dell'infanzia e dell'adolescenza. / Russo, A.; Posar, A.; Conti, S.; Parmeggiani, A.

In: Bollettino - Lega Italiana contro l'Epilessia, No. 145, 04.2013, p. 117-124.

Research output: Contribution to journalArticle

@article{16042ec22bdb431580a33403a4724277,
title = "Fattori prognostici di farmacoresistenza nell'epilessia dell'infanzia e dell'adolescenza",
abstract = "The International League Against Epilepsy (ILAE) has recently defined drug resistance (DR) as a failure of adequate trials of two tolerated and appropriately chosen and used AED schedules (whether as monotherapies or in combination) to achieve sustained seizure freedom. We studied the prognostic factors of DR in 117 patients affected by epilepsy with onset during childhood or adolescence, with a mean age at the first and the last observation respectively of 3 yrs 3 mths and 9 yrs 10 mths. Patients were divided into two groups: one with DR and the other one without DR. In DR cases some parameters prevailed, in particular presence of symptomatic etiology, lesions on MRI, EEG abnormalities at the onset and positive neurological examination, seizure frequency and seizure clustering, poor or delayed response to first AED. PB, VPA, and CBZ were the most utilized drugs. We reviewed the most relevant 10 variables by multiple logistic regression. The most reliable combinations of DR predictors are: partial or no response to the first AED, the presence of seizure clustering during the course of epilepsy, slightly or very altered neurological examination and long latency between onset of epilepsy and first AED administered at T2; partial or no response to the first AED and positive MRI at T5; positive MRI and absence of generalized seizures at T8; and positive MRI at T10. Our data show that 14.4{\%} of the subjects at T5, 16.6{\%} at T8 and 24.3{\%} at T10 became drug-resistant after discontinuation of an efficacious therapy.",
keywords = "Adolescence, Childhood, Diagnosis, Drug-resistance, Epilepsy, Long term follow-up, Prognosis",
author = "A. Russo and A. Posar and S. Conti and A. Parmeggiani",
year = "2013",
month = "4",
language = "Italian",
pages = "117--124",
journal = "Bollettino - Lega Italiana contro l'Epilessia",
issn = "0394-560X",
publisher = "Lega Italiana contro l'Epilessia",
number = "145",

}

TY - JOUR

T1 - Fattori prognostici di farmacoresistenza nell'epilessia dell'infanzia e dell'adolescenza

AU - Russo, A.

AU - Posar, A.

AU - Conti, S.

AU - Parmeggiani, A.

PY - 2013/4

Y1 - 2013/4

N2 - The International League Against Epilepsy (ILAE) has recently defined drug resistance (DR) as a failure of adequate trials of two tolerated and appropriately chosen and used AED schedules (whether as monotherapies or in combination) to achieve sustained seizure freedom. We studied the prognostic factors of DR in 117 patients affected by epilepsy with onset during childhood or adolescence, with a mean age at the first and the last observation respectively of 3 yrs 3 mths and 9 yrs 10 mths. Patients were divided into two groups: one with DR and the other one without DR. In DR cases some parameters prevailed, in particular presence of symptomatic etiology, lesions on MRI, EEG abnormalities at the onset and positive neurological examination, seizure frequency and seizure clustering, poor or delayed response to first AED. PB, VPA, and CBZ were the most utilized drugs. We reviewed the most relevant 10 variables by multiple logistic regression. The most reliable combinations of DR predictors are: partial or no response to the first AED, the presence of seizure clustering during the course of epilepsy, slightly or very altered neurological examination and long latency between onset of epilepsy and first AED administered at T2; partial or no response to the first AED and positive MRI at T5; positive MRI and absence of generalized seizures at T8; and positive MRI at T10. Our data show that 14.4% of the subjects at T5, 16.6% at T8 and 24.3% at T10 became drug-resistant after discontinuation of an efficacious therapy.

AB - The International League Against Epilepsy (ILAE) has recently defined drug resistance (DR) as a failure of adequate trials of two tolerated and appropriately chosen and used AED schedules (whether as monotherapies or in combination) to achieve sustained seizure freedom. We studied the prognostic factors of DR in 117 patients affected by epilepsy with onset during childhood or adolescence, with a mean age at the first and the last observation respectively of 3 yrs 3 mths and 9 yrs 10 mths. Patients were divided into two groups: one with DR and the other one without DR. In DR cases some parameters prevailed, in particular presence of symptomatic etiology, lesions on MRI, EEG abnormalities at the onset and positive neurological examination, seizure frequency and seizure clustering, poor or delayed response to first AED. PB, VPA, and CBZ were the most utilized drugs. We reviewed the most relevant 10 variables by multiple logistic regression. The most reliable combinations of DR predictors are: partial or no response to the first AED, the presence of seizure clustering during the course of epilepsy, slightly or very altered neurological examination and long latency between onset of epilepsy and first AED administered at T2; partial or no response to the first AED and positive MRI at T5; positive MRI and absence of generalized seizures at T8; and positive MRI at T10. Our data show that 14.4% of the subjects at T5, 16.6% at T8 and 24.3% at T10 became drug-resistant after discontinuation of an efficacious therapy.

KW - Adolescence

KW - Childhood

KW - Diagnosis

KW - Drug-resistance

KW - Epilepsy

KW - Long term follow-up

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=84887267543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887267543&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:84887267543

SP - 117

EP - 124

JO - Bollettino - Lega Italiana contro l'Epilessia

JF - Bollettino - Lega Italiana contro l'Epilessia

SN - 0394-560X

IS - 145

ER -